Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
|
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [1] The Cumulative Risk of False-Positive Fecal Occult Blood Test after 10 Years of Colorectal Cancer Screening
    Hubbard, Rebecca A.
    Johnson, Eric
    Hsia, Raymond
    Rutter, Carolyn M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1612 - 1619
  • [2] SENSITIVITY AND REPRODUCIBILITY OF CHEMICAL TESTS FOR FECAL OCCULT BLOOD WITH AN EMPHASIS ON FALSE-POSITIVE REACTIONS
    OSTROW, JD
    MULVANEY, CA
    HANSELL, JR
    RHODES, RS
    AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1973, 18 (11): : 930 - 940
  • [3] HEMATURIA AND FALSE-POSITIVE TESTS FOR STOOL OCCULT BLOOD
    DARDICK, KR
    AMERICAN FAMILY PHYSICIAN, 1984, 29 (02) : 201 - 202
  • [4] RED FRUITS CAUSING FALSE-POSITIVE OCCULT BLOOD TESTS IN STOOL
    WIENER, SL
    WIENER, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (08): : 408 - 408
  • [5] DESICCATED LIVER AND FALSE-POSITIVE FECAL OCCULT BLOOD TEST-RESULTS
    SPEICHER, CE
    ROBERTS, WH
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (13): : 1769 - 1769
  • [6] The Appropriateness of Colorectal Cancer Screening by Fecal Occult Blood Tests
    Lippi, Giuseppe
    Brocco, Giorgio
    Guidi, Gian C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03): : 800 - 801
  • [7] Factors associated with false-positive fecal immunochemical tests in a large German colorectal cancer screening study
    Amitay, Efrat L.
    Cuk, Katarina
    Niedermaier, Tobias
    Weigl, Korbinian
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2419 - 2427
  • [8] How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis
    Haug, Ulrike
    Knudsen, Amy B.
    Kuntz, Karen M.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (09) : 2094 - 2102
  • [9] False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening
    van Rossum, Leo G. M.
    van Rijn, Anne F.
    van Oijen, Martijn G. H.
    Fockens, Paul
    Laheij, Robert J. F.
    Verbeek, Andre L. M.
    Jansen, Jan B. M. J.
    Dekker, Evelien
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 746 - 750
  • [10] Immunochemical fecal occult blood tests for colorectal cancer screening - Reply
    Ko, C
    Dominitz, J
    Nguyen, T
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (07): : 498 - 499